Cargando…

When ‘mild’ COVID-19 is not so mild

Detalles Bibliográficos
Autor principal:	Minton, Kirsty
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244390/ https://www.ncbi.nlm.nih.gov/pubmed/35768517 http://dx.doi.org/10.1038/s41577-022-00755-8

Ejemplares similares

GCS 15: when mild TBI isn’t so mild
por: Ganti, Latha, et al.
Publicado: (2019)

Neutralizing antibody response in mild COVID-19
por: van der Heide, Verena
Publicado: (2020)

Mechanistic insights into Long COVID in hamsters
por: Minton, Kirsty
Publicado: (2022)

Coordinated and sustained immune memory responses after mild COVID-19
por: Alrubayyi, Aljawharah
Publicado: (2020)

Do rogue antibodies make the difference between mild versus severe COVID-19?
por: Flemming, Alexandra
Publicado: (2021)

Neutralization susceptibility of Omicron lineages
por: Minton, Kirsty
Publicado: (2022)

Hydroxychloroquine: small effects in mild disease
por: Levantovsky, Rachel, et al.
Publicado: (2020)

Early prone positioning therapy for patients with mild COVID-19 disease
por: Liu, Xiaoyi, et al.
Publicado: (2021)

The diagnostic value of platelet distribution width in patients with mild COVID‐19
por: Wang, Yan, et al.
Publicado: (2021)

Early prone positioning therapy for patients with mild COVID-19 disease
por: Liu, Xiaoyi, et al.
Publicado: (2021)

Lingering cardiac involvement in previously well people after mild COVID-19
Publicado: (2022)

Self-Assessment Questionnaire for Efficient and Safe Evaluation of Patients with Mild COVID-19
por: Jeong, Hyeongseok, et al.
Publicado: (2020)

Investigation and Analysis of 108 Cases of Home Isolated Patients With Mild COVID-19
por: Li, Hang, et al.
Publicado: (2020)

Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain()
por: Ninchritz-Becerra, Elisabeth, et al.
Publicado: (2021)

V232D mutation in patients with cystic fibrosis: Not so rare, not so mild
por: Fernández-Lorenzo, Ana E., et al.
Publicado: (2018)

Limited Benefit of Facility Isolation and the Rationale for Home Care in Children with Mild COVID-19
por: Yun, Ki Wook, et al.
Publicado: (2021)

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19
por: Apple, Alexandra C., et al.
Publicado: (2022)

Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection
por: Vicenti, Ilaria, et al.
Publicado: (2021)

Mild acute pancreatitis with vildagliptin use
por: Saraogi, Ravikant, et al.
Publicado: (2012)

Primary Angiosarcoma of the Skin Presenting as Mild Erythema
por: Moon, Sun Young, et al.
Publicado: (2017)

Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages
por: Bohnacker, Sina, et al.
Publicado: (2022)

Persistent olfactory dysfunction in mild COVID-19 patients: A descriptive study of the characteristics and association with other symptoms
por: García-Meléndez, David Dylan, et al.
Publicado: (2023)

Persistent olfactory dysfunction in mild COVID-19 patients: A descriptive study of the characteristics and association with other symptoms
por: García-Meléndez, David Dylan, et al.
Publicado: (2023)

Not so mild: emergency department utilization after index COVID infection stratified by disease severity
por: Bastani, Aveh, et al.
Publicado: (2022)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

Changes in sleep phase and body weight of mobile health App users during COVID-19 mild lockdown in Japan
por: Tahara, Yu, et al.
Publicado: (2021)

Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience
por: Amanam, Idoroenyi, et al.
Publicado: (2023)

Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies
por: Jary, Aude, et al.
Publicado: (2022)

The Alzheimer’s disease metabolic brain pattern in mild cognitive impairment
por: Meles, Sanne K, et al.
Publicado: (2017)

DEFINITIONS MATTER WHEN DIAGNOSING MILD COGNITIVE IMPAIRMENT
por: Derby, Carol, et al.
Publicado: (2019)

Lymphocyte Subsets in Mild COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Azithromycin for mild-to-moderate COVID-19
por: Patel, Jigar, et al.
Publicado: (2021)

Innovation Inspired by COVID: A Virtual Treatment Program for Patients With Mild Cognitive Impairment at Mayo Clinic
por: Locke, Dona E.C., et al.
Publicado: (2021)

Biallelic loss of EMC10 leads to mild to severe intellectual disability
por: Kaiyrzhanov, Rauan, et al.
Publicado: (2022)

Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits
por: Perrotta, Gaetano, et al.
Publicado: (2017)

Clinical relevance of microhemorrhagic lesions in subacute mild traumatic brain injury
por: van der Horn, H. J., et al.
Publicado: (2017)

BTV-14 Infection in Sheep Elicits Viraemia with Mild Clinical Symptoms
por: Flannery, John, et al.
Publicado: (2020)

Crossreactivity not so helpful after all?
por: Flemming, Alexandra
Publicado: (2021)

Mild Hypothyroidism in Childhood: Who, When, and How Should Be Treated?
por: Vigone, Maria Cristina, et al.
Publicado: (2018)

Gaps between Activities of Daily Living Performance and Capacity in People with Mild Dementia
por: Nakanishi, Kosuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ia7qh3a8ul70iinj4rta0m63hv